Close
  • Home
  • Gene
  • ERBB2 & CD3
Loading...

ERBB2 & CD3

Engineered Antibody Antibody-like Scaffold Protein Glyco-Abs MHC scTCR
This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.
The protein encoded by this gene is part of the T-cell receptor/CD3 complex (TCR/CD3 complex) and is involved in T-cell development and signal transduction. The encoded membrane protein represents the delta subunit of the CD3 complex, and along with four other CD3 subunits, binds either TCR alpha/beta or TCR gamma/delta to form the TCR/CD3 complex on the surface of T-cells. Defects in this gene are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (SCIDBNK). Two transcript variants encoding different isoforms have been found for this gene. Other variants may also exist, but the full-length natures of their transcripts has yet to be defined.

  • Anti-HER2 (clone cFRP5)-SPP-DM1 ADC (ADC-066LZY)

    • Target: HER2
    • Linker: SPP(N-succinimidyl-4-(2-pyridyldithio)pentanoate)
    • Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)

  • Anti-HER2-MT-vc-MMAE ADC (ADC-257CL)

    • Target: HER2
    • Linker: MT-VC
    • Drug: (S,E)-N-(4-aminophenylsulfonyl)-2,5-dimethyl-4-((S)-N,3,3-trimethyl-2-((S)-3-methyl-2-(methylamino)-3-phenylbutanamido)butanamido)hex-2-enamide

  • Anti-HER2-SMCC-maytansine ADC (ADC-065LZY)

    • Target: HER2
    • Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
    • Drug: maytansine

  • Anti-HER2-MC-vc-PABC-MMAE ADC (ADC-256CL)

    • Target: HER2
    • Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
    • Drug: (S,E)-N-(4-(aminomethyl)benzylsulfonyl)-2,5-dimethyl-4-((S)-N,3,3-trimethyl-2-((S)-3-methyl-2-(methylamino)-3-phenylbutanamido)butanamido)hex-2-enamide

  • Anti-HER2-NGMs-MMAE ADC (ADC-035LZY)

    • Target: HER2
    • Linker: NGMs(next generation maleimides)
    • Drug: MMAE (monomethyl auristatin E)

  • Anti-HER2-MP(T-vc)-MMAE ADC (ADC-255CL)

    • Target: HER2
    • Linker: MP(T-VC)
    • Drug: (S,E)-N-(4-aminophenylsulfonyl)-2,5-dimethyl-4-((S)-N,3,3-trimethyl-2-((S)-3-methyl-2-(methylamino) phenylbutanamido)butanamido)hex-2-enamide

  • Anti-HER2-SMCC-DM1 ADC (ADC-001LZY)

    • Target: HER2
    • Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
    • Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)

  • Anti-HER2-MT-vc-MMAE ADC (ADC-254CL)

    • Target: HER2
    • Linker: MT-VC
    • Drug: (S,E)-N-(4-aminophenylsulfonyl)-2,5-dimethyl-4-((S)-N,3,3-trimethyl-2-((S)-3-methyl-2-(methylamino)-3-phenylbutanamido)butanamido)hex-2-enamide

  • Anti-HER2-MT-vc-MMAE ADC (ADC-253CL)

    • Target: HER2
    • Linker: MT-VC
    • Drug: (S,E)-N-(4-aminophenylsulfonyl)-2,5-dimethyl-4-((S)-N,3,3-trimethyl-2-((S)-3-methyl-2-(methylamino)-3-phenylbutanamido)butanamido)hex-2-enamide

  • Anti-HER2-MT-vc-MMAE ADC (ADC-252CL)

    • Target: HER2
    • Linker: MT-VC
    • Drug: (S,E)-N-(4-aminophenylsulfonyl)-2,5-dimethyl-4-((S)-N,3,3-trimethyl-2-((S)-3-methyl-2-(methylamino)-3-phenylbutanamido)butanamido)hex-2-enamide

  • Anti-HER2-MT-vc-MMAE ADC (ADC-251CL)

    • Target: HER2
    • Linker: MT-VC
    • Drug: (S,E)-N-(4-aminophenylsulfonyl)-2,5-dimethyl-4-((S)-N,3,3-trimethyl-2-((S)-3-methyl-2-(methylamino)-3-phenylbutanamido)butanamido)hex-2-enamide

  • Anti-HER2-BMPEO-DM1 ADC (ADC-186CL)

    • Target: HER2
    • Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
    • Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)

  • Anti-HER2-MT-vc-MMAE ADC (ADC-250CL)

    • Target: HER2
    • Linker: MT-VC
    • Drug: (S,E)-N-(4-aminophenylsulfonyl)-2,5-dimethyl-4-((S)-N,3,3-trimethyl-2-((S)-3-methyl-2-(methylamino)-3-phenylbutanamido)butanamido)hex-2-enamide

  • Anti-HER2-vcPAB-MMAE ADC (ADC-148CL)

    • Target: HER2
    • Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
    • Drug: MMAE (Monomethyl auristatin E)

  • Anti-HER2-MT-vc-MMAE ADC (ADC-249CL)

    • Target: HER2
    • Linker: MT-VC
    • Drug: (S,E)-N-(4-aminophenylsulfonyl)-2,5-dimethyl-4-((S)-N,3,3-trimethyl-2-((S)-3-methyl-2-(methylamino)-3-phenylbutanamido)butanamido)hex-2-enamide

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

© 2007 - 2020 Creative BioLabs All Rights Reserved
  • 0
  • 0

Cart

    Inquiry